Treatment of neuroblastoma with /sup 131/I-metaiodobenzylguanidine: experience of the Muenster/Kassel Group

Journal Article · Thu Jan 01 00:00:00 EST 1987 · Med. Pediatr. Oncol.; (United States)

DOI:https://doi.org/10.1002/mpo.2950150411· OSTI ID:5849350

Fischer, M; Wehinger, H; Kraus, C; Ritter, J; Schroeter, W

I-131-metaiodobenzylguanidine was used for treatment of neuroblastoma stage IV in three children after surgery and or chemotherapy had failed to be effective. In two of the children with multilocular lesions, after an impressive improvement of clinical symptoms tumor progression was observed. Because in about 25% of children with relapsing neuroblastoma complete remission may be achieved by combining surgery, chemotherapy, and I-131-MIBG treatment, this therapeutic modality should be included in the therapeutic strategy of stage III and IV neuroblastoma.

• Research Organization: Staedtische Kliniken Kassel, Germany, F.R.
• OSTI ID: 5849350
• Journal Information: Med. Pediatr. Oncol.; (United States), Vol. 15:4
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
NEOPLASMS
COMBINED THERAPY
RADIOPHARMACEUTICALS
THERAPEUTIC USES
CHILDREN
IODINE 131
AGE GROUPS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
DAYS LIVING RADIOISOTOPES
DISEASES
DRUGS
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
NUCLEI
ODD-EVEN NUCLEI
RADIOISOTOPES
THERAPY
USES
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)
550600 - Medicine